Dicyclomine Hydrochloride Tablet
Product Images NDC 67296-2154

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 67296-2154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg (100 Tablet Bottle))

Package Label-principal Display Panel (20 mg (100 Tablet Bottle))
This text provides information about a medication with the NDC 59651-720-01, containing Dicyclomine Hydrochloride in tablet form (20 mg per tablet). The document includes instructions for storage, dispensing, and dosing. The medication is distributed by Aurobindo Pharma USA, Inc., with an address in East Windsor, NJ, and is manufactured in India. Additional details such as the prescription-only status, quantity, and packaging instructions are also provided.*
FDA Label Image

Chemical Formula (Dicyclomine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.